On-site Diabetic Retinopathy Screening that is immediate and fully-automated.

Diabetic eye screening that happens in the Primary Care setting:

  • Diagnosis in less than 10 seconds
  • No human grader needed
  • No eyecare specialist needed on-site
Diagnosis in less than 10 seconds
Meet RETINA-AI Galaxy

Artificial Intelligence for Diabetic Retinopathy

Diabetic retinopathy is the leading cause of blindness in working age adults. But it can be prevented with early detection and treatment. We are using deep learning to automatically detect moderate or worse Diabetic Retinopathy (mowDRet) in the Primary Care Setting. Patients in whom moderate or worse Diabetic Retinopathy (mowDRet) is detected are to be referred to an Eye Care Professional, and Patients in whom moderate or worse Diabetic Retinopathy (mowDRet) is not detected are to repeat the RETINA-AI Galaxy exam in 12 months.

Works with multiple cameras
Easy to use
FDA clearance pending
Prevents blindness
Same day results
Fast and secure
RETINA-AI is for
  • PCPs
  • Insurers / Payors
  • Patients
Add a new revenue stream (CPT code 92229). Will be reimbursed by Medicare and major healthcare insurance providers.
  • Improve HEDIS® Measures & CMS Star Ratings.
  • Quick results generated in the same visit.
  • Remove patient compliance obstacles.
  • Easy training for any medical assistant

How Galaxy works

Capture images

A trained medical assistant takes images of patient’s retina (two per eye).

Analyzes images

Galaxy analyzes images for markers that indicate disease. Provides results in less than 10 sec.

Diagnostic report

Output diagnosis report. Results are either: No disease detected, retest in 12 months or disease detected, refer to an eyecare professional.

Galaxy AI sensitivity exceeds 90% for moderate or worse Diabetic Retinopathy (mowDRet) on each camera.

Galaxy AI sensitivity exceeds 95% for vision threatening Diabetic Retinopathy (vtDR) on each camera.

Most technologically advanced.

We are the first and only to have multi-camera compatibility with 3 different camera manufacturers.

The RETINA-AI Galaxy is intended for use with any of the following robotic cameras: Centervue DRSPlus, Crystalvue NFC-700, or Topcon NW400. The DRSplus is a favorite amongst clinic staff. It is the highest performing and most technologically advanced option. The Crystalvue NFC-700 is also an excellent and cost-effective option. The Topcon NW400 is a well known and highly available.


A robotic camera has no joystick, so no manual human-adjustments are needed. The camera will adjust itself until it finds the patient’s eye. This makes training very easy for any Medical Assistant to quickly learn how to conduct an exam.


No previous eyecare-specific specialty training is required. Whereas non-robotic (joystick) cameras require much more adjustment from a human operator, can be more error prone, and can take longer to train your staff.

CenterVue (DRSplus)
Clinical trial proves that Galaxy is safe and effective. In a pivotal study Galaxy on DRSplus performed at:

90.3% sensitivity and 85% specificity.

More than 94% of patients did not need to be dilated.

Easy Training for Anyone in the Clinic

Designed for intentional ease of use. Any operator, with no specialized skills, can be trained in a short amount of time

  • Operators could be Medical Assistants, Nursing Assistants, or Nurses, etc.
  • Short amount of training and very easy to use.
  • Don’t need any prior ophthalmic experience.
Time is precious for both clinical staff and patients. Therefore a diagnosis is given in less than 3 seconds* after images are sent.
*Based on “low” internet speeds of at least 58.6 Mbps download/4.5Mbps upload.

A report that everyone can understand

Galaxy provides an easy-to-read, and actionable report with follow-up timelines and referrals perfectly aligned with the American Academy of Ophthalmology (AAO) Diabetic Retinopathy Preferred Practice Pattern .

We are experts

Our team is made up of healthcare experts from:

Keep an eye on the health of your patients.